-
1
-
-
79952232216
-
Global cancer statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
-
2
-
-
0035140369
-
Epidemiology of hepatocellular carcinoma
-
El-Serag HB (2001) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 5: 87-107, vi.
-
(2001)
Clin Liver Dis
, vol.5
-
-
El-Serag, H.B.1
-
3
-
-
33646413672
-
The global health burden of infection-associated cancers in the year 2002
-
Parkin DM, (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030-3044.
-
(2006)
Int J Cancer
, vol.118
, pp. 3030-3044
-
-
Parkin, D.M.1
-
4
-
-
31144437639
-
Hepatocellular carcinoma: therapy and prevention
-
Blum HE, (2005) Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol 11: 7391-7400.
-
(2005)
World J Gastroenterol
, vol.11
, pp. 7391-7400
-
-
Blum, H.E.1
-
5
-
-
0034720287
-
Evaluation of abnormal liver-enzyme results in asymptomatic patients
-
Pratt DS, Kaplan MM, (2000) Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 342: 1266-1271.
-
(2000)
N Engl J Med
, vol.342
, pp. 1266-1271
-
-
Pratt, D.S.1
Kaplan, M.M.2
-
6
-
-
13444282229
-
Liver enzyme alteration: a guide for clinicians
-
Giannini EG, Testa R, Savarino V, (2005) Liver enzyme alteration: a guide for clinicians. CMAJ 172: 367-379.
-
(2005)
CMAJ
, vol.172
, pp. 367-379
-
-
Giannini, E.G.1
Testa, R.2
Savarino, V.3
-
7
-
-
45549092142
-
Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study
-
Strasak AM, Rapp K, Brant LJ, Hilbe W, Gregory M, et al. (2008) Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res 68: 3970-3977.
-
(2008)
Cancer Res
, vol.68
, pp. 3970-3977
-
-
Strasak, A.M.1
Rapp, K.2
Brant, L.J.3
Hilbe, W.4
Gregory, M.5
-
8
-
-
77951745290
-
Prospective study of the association of serum gamma-glutamyltransferase with cervical intraepithelial neoplasia III and invasive cervical cancer
-
Strasak AM, Goebel G, Concin H, Pfeiffer RM, Brant LJ, et al. (2010) Prospective study of the association of serum gamma-glutamyltransferase with cervical intraepithelial neoplasia III and invasive cervical cancer. Cancer Res 70: 3586-3593.
-
(2010)
Cancer Res
, vol.70
, pp. 3586-3593
-
-
Strasak, A.M.1
Goebel, G.2
Concin, H.3
Pfeiffer, R.M.4
Brant, L.J.5
-
9
-
-
40949103928
-
Serum aminotransferase activity and mortality risk in a United States community
-
Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ, 3rd
-
Lee TH, Kim WR, Benson JT, Therneau TM, Melton LJ, 3rd (2008) Serum aminotransferase activity and mortality risk in a United States community. Hepatology 47: 880-887.
-
(2008)
Hepatology
, vol.47
, pp. 880-887
-
-
-
10
-
-
77949401124
-
Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values
-
Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, et al. (2010) Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values. J Med Virol 82: 539-545.
-
(2010)
J Med Virol
, vol.82
, pp. 539-545
-
-
Kumada, T.1
Toyoda, H.2
Kiriyama, S.3
Sone, Y.4
Tanikawa, M.5
-
11
-
-
16344381152
-
Factors associated with response to lamivudine: Retrospective study in a tertiary care clinic serving patients with chronic hepatitis B. J Gastroenterol Hepatol
-
Hann HW, Jonsson Funk ML, Rosenberg DM, Davis R, (2005) Factors associated with response to lamivudine: Retrospective study in a tertiary care clinic serving patients with chronic hepatitis B. J Gastroenterol Hepatol. 20: 433-440.
-
(2005)
, vol.20
, pp. 433-440
-
-
Hann, H.W.1
Jonsson Funk, M.L.2
Rosenberg, D.M.3
Davis, R.4
-
12
-
-
0003946030
-
-
Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Environmental Health, National Center for Health Statistics
-
Gunter EW LB, Koncikowski SM, editor (1996) Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994.: Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Environmental Health, National Center for Health Statistics.
-
(1996)
Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994
-
-
Gunter, E.W.1
Koncikowski, S.M.2
-
13
-
-
58649083017
-
Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population
-
Ruhl CE, Everhart JE (2009) Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 136: 477-485 e411.
-
(2009)
Gastroenterology
, vol.136
-
-
Ruhl, C.E.1
Everhart, J.E.2
-
14
-
-
29944436855
-
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
-
Chen CJ, Yang HI, Su J, Jen CL, You SL, et al. (2006) Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73.
-
(2006)
JAMA
, vol.295
, pp. 65-73
-
-
Chen, C.J.1
Yang, H.I.2
Su, J.3
Jen, C.L.4
You, S.L.5
-
15
-
-
77952796951
-
When and how to evaluate mildly elevated liver enzymes in apparently healthy patients
-
Aragon G, Younossi ZM, (2010) When and how to evaluate mildly elevated liver enzymes in apparently healthy patients. Cleve Clin J Med 77: 195-204.
-
(2010)
Cleve Clin J Med
, vol.77
, pp. 195-204
-
-
Aragon, G.1
Younossi, Z.M.2
-
16
-
-
0001472723
-
The clinical significance of transaminase activities of serum
-
Wroblewski F, (1959) The clinical significance of transaminase activities of serum. Am J Med 27: 911-923.
-
(1959)
Am J Med
, vol.27
, pp. 911-923
-
-
Wroblewski, F.1
-
17
-
-
0036787433
-
AGA technical review on the evaluation of liver chemistry tests
-
Green RM, Flamm S, (2002) AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 123: 1367-1384.
-
(2002)
Gastroenterology
, vol.123
, pp. 1367-1384
-
-
Green, R.M.1
Flamm, S.2
-
18
-
-
42249103062
-
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease
-
Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC, (2008) Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47: 1363-1370.
-
(2008)
Hepatology
, vol.47
, pp. 1363-1370
-
-
Kim, W.R.1
Flamm, S.L.2
Di Bisceglie, A.M.3
Bodenheimer, H.C.4
-
19
-
-
77951483260
-
Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology
-
Lee JK, Shim JH, Lee HC, Lee SH, Kim KM, et al. (2010) Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology. Hepatology 51: 1577-1583.
-
(2010)
Hepatology
, vol.51
, pp. 1577-1583
-
-
Lee, J.K.1
Shim, J.H.2
Lee, H.C.3
Lee, S.H.4
Kim, K.M.5
-
20
-
-
0037008087
-
Updated definitions of healthy ranges for serum alanine aminotransferase levels
-
Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, et al. (2002) Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 137: 1-10.
-
(2002)
Ann Intern Med
, vol.137
, pp. 1-10
-
-
Prati, D.1
Taioli, E.2
Zanella, A.3
Della Torre, E.4
Butelli, S.5
-
21
-
-
67649199520
-
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time
-
Tai DI, Lin SM, Sheen IS, Chu CM, Lin DY, et al. (2009) Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time. Hepatology 49: 1859-1867.
-
(2009)
Hepatology
, vol.49
, pp. 1859-1867
-
-
Tai, D.I.1
Lin, S.M.2
Sheen, I.S.3
Chu, C.M.4
Lin, D.Y.5
-
22
-
-
79959622830
-
Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels
-
Nakazawa T, Shibuya A, Takeuchi A, Shibata Y, Hidaka H, et al. (2011) Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels. J Viral Hepat 18: e191-199.
-
(2011)
J Viral Hepat
, vol.18
-
-
Nakazawa, T.1
Shibuya, A.2
Takeuchi, A.3
Shibata, Y.4
Hidaka, H.5
-
23
-
-
35748984106
-
The clinical significance of persistently normal ALT in chronic hepatitis B infection
-
Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH, (2007) The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol 47: 760-767.
-
(2007)
J Hepatol
, vol.47
, pp. 760-767
-
-
Lai, M.1
Hyatt, B.J.2
Nasser, I.3
Curry, M.4
Afdhal, N.H.5
-
24
-
-
35648952818
-
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology
-
Chu CM, Liaw YF, (2007) Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology. 133: 1458-1465.
-
(2007)
, vol.133
, pp. 1458-1465
-
-
Chu, C.M.1
Liaw, Y.F.2
-
25
-
-
0032412523
-
AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection
-
Sheth SG, Flamm SL, Gordon FD, Chopra S, (1998) AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 93: 44-48.
-
(1998)
Am J Gastroenterol
, vol.93
, pp. 44-48
-
-
Sheth, S.G.1
Flamm, S.L.2
Gordon, F.D.3
Chopra, S.4
-
26
-
-
57149086471
-
Body-mass index and progression of hepatitis B: a population-based cohort study in men
-
Yu MW, Shih WL, Lin CL, Liu CJ, Jian JW, et al. (2008) Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol 26: 5576-5582.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5576-5582
-
-
Yu, M.W.1
Shih, W.L.2
Lin, C.L.3
Liu, C.J.4
Jian, J.W.5
-
27
-
-
0015318618
-
Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone
-
Lum G, Gambino SR, (1972) Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone. Clin Chem 18: 358-362.
-
(1972)
Clin Chem
, vol.18
, pp. 358-362
-
-
Lum, G.1
Gambino, S.R.2
-
28
-
-
0034837235
-
Gamma glutamyl transferase
-
Whitfield JB, (2001) Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38: 263-355.
-
(2001)
Crit Rev Clin Lab Sci
, vol.38
, pp. 263-355
-
-
Whitfield, J.B.1
-
29
-
-
80051874500
-
Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study
-
Van Hemelrijck M, Jassem W, Walldius G, Fentiman IS, Hammar N, et al. (2011) Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons- the Swedish AMORIS study. Eur J Cancer 47: 2033-2041.
-
(2011)
Eur J Cancer
, vol.47
, pp. 2033-2041
-
-
Van Hemelrijck, M.1
Jassem, W.2
Walldius, G.3
Fentiman, I.S.4
Hammar, N.5
-
30
-
-
0015393860
-
Serum -glytamyl transpeptidase activity in liver disease
-
Whitfield JB, Pounder RE, Neale G, Moss DW, (1972) Serum-glytamyl transpeptidase activity in liver disease. Gut 13: 702-708.
-
(1972)
Gut
, vol.13
, pp. 702-708
-
-
Whitfield, J.B.1
Pounder, R.E.2
Neale, G.3
Moss, D.W.4
-
31
-
-
0015478297
-
Gamma-glutamyl transpeptidase: a clinical and experimental study
-
Ideo G, Morganti A, Dioguardi N, (1972) Gamma-glutamyl transpeptidase: a clinical and experimental study. Digestion 5: 326-336.
-
(1972)
Digestion
, vol.5
, pp. 326-336
-
-
Ideo, G.1
Morganti, A.2
Dioguardi, N.3
-
32
-
-
34548081774
-
Gamma-glutamyltransferase, redox regulation and cancer drug resistance
-
Pompella A, Corti A, Paolicchi A, Giommarelli C, Zunino F, (2007) Gamma-glutamyltransferase, redox regulation and cancer drug resistance. Curr Opin Pharmacol 7: 360-366.
-
(2007)
Curr Opin Pharmacol
, vol.7
, pp. 360-366
-
-
Pompella, A.1
Corti, A.2
Paolicchi, A.3
Giommarelli, C.4
Zunino, F.5
-
33
-
-
77956574773
-
Pathological aspects of lipid peroxidation
-
Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, et al. (2010) Pathological aspects of lipid peroxidation. Free Radic Res 44: 1125-1171.
-
(2010)
Free Radic Res
, vol.44
, pp. 1125-1171
-
-
Negre-Salvayre, A.1
Auge, N.2
Ayala, V.3
Basaga, H.4
Boada, J.5
-
34
-
-
79955867373
-
Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study
-
Zhao J, Zhao Y, Wang H, Gu X, Ji J, et al. (2011) Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study. Nutr J 10: 49.
-
(2011)
Nutr J
, vol.10
, pp. 49
-
-
Zhao, J.1
Zhao, Y.2
Wang, H.3
Gu, X.4
Ji, J.5
-
35
-
-
75349084543
-
Risk of HCC: genetic heterogeneity and complex genetics
-
Dragani TA, (2010) Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol 52: 252-257.
-
(2010)
J Hepatol
, vol.52
, pp. 252-257
-
-
Dragani, T.A.1
-
36
-
-
0029869768
-
Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study
-
Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, et al. (1996) Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 23: 1025-1029.
-
(1996)
Hepatology
, vol.23
, pp. 1025-1029
-
-
Becker, U.1
Deis, A.2
Sorensen, T.I.3
Gronbaek, M.4
Borch-Johnsen, K.5
-
37
-
-
12444285909
-
Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma
-
Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, et al. (2005) Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42: 218-224.
-
(2005)
J Hepatol
, vol.42
, pp. 218-224
-
-
Marrero, J.A.1
Fontana, R.J.2
Fu, S.3
Conjeevaram, H.S.4
Su, G.L.5
|